Email:shdiahds@163.com
Phone:+1-909-839-7620
Fax:+1-909-839-7620
Click here for qusetions for this product!
Polyclonal and Monoclonal antibody center
Home
Contact us
Sitemap
Current Country :
Download PDF DatasheetCatalogue No : BS2864
| Host | Reactivity | Size | Application | stock | price | cart |
| BS2864 | H,R | 100ug | IHC | ![]() |
258.00 | ![]() |
|
Contact information
Email:shdiahds@163.com Click here for qusetions for this product! |
||||||
1 mg/ml in Phosphate buffered saline (PBS) with 15 mM sodium azide, approx. pH 7.2.
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen and the purity is > 95% (by SDS-PAGE).
BRCA2 (N60) antibody detects endogenous levels of BRCA2 protein.
IHC: 1:50~1:200

Immunohistochemistry (IHC) analyzes of BRCA2 (N60) antibody in paraffin-embedded human breast carcinoma tissue.
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
BRCA 2 is localized to chromosome 13q12 - q13. Loss of heterozygosity of 13q is observed in 25% of sporadic breast tumors, which indicates that BRCA 2 might be a tumor suppressor gene. BRCA 2 confers only a low ovarian cancer risk. Reportedly, in MCF-10F (normal breast epithelial cell line) and MCF-7 (breast cancer cell line) cells the expression of BRCA 2 RNA lowers in G0 and early G1 phases then gets up-regulated at the G1 / S phase junction.